ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
INVESTORS
[이데일리] 항체·면역항암제 전문가 의기투합…혈액암 완치율 높일 것
2019/04/26
항체·면역항암제 전문가 의기투합…혈액암 완치율 높일 것 (edaily.co.kr)
이데일리 강경훈 기자
Prev
[히트뉴스] 연구기획자의 바이오벤처 창업을 준비하는 자세
Next
[한국경제] “노바티스 ‘킴리아’ 뛰어넘는 차세대 항암 CAR-T 치료제 내년 임상”
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.